Beiqi Biology Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 12

Beiqi Biology General Information

Description

Developer of biopharmaceutical products designed for therapeutic research and clinical application. The company utilizes a proprietary chemical reprogramming platform and molecular biology techniques to target somatic cell transformation, providing healthcare institutions with human chemically induced pluripotent stem cell kits, blood cell chemical reprogramming kits, off-the-shelf cell therapies, specialized cell culture media, regenerative medicine research tools, and disease modeling kits to advance treatment development.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 201, 2nd Floor, Xinggu Courtyard
  • Number 4 Yongjia North Road, Haidian District
  • Beijing
  • China
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Room 201, 2nd Floor, Xinggu Courtyard
  • Number 4 Yongjia North Road, Haidian District
  • Beijing
  • China

Beiqi Biology Timeline

2023202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beiqi Biology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC Completed Generating Revenue
3. Early Stage VC (Series A1) 29-Dec-2025 Completed Generating Revenue
2. Early Stage VC (Series A) 11-Dec-2024 $13.8M $13.8M Completed Generating Revenue
1. Seed Round 20-Dec-2022 Completed Startup
To view Beiqi Biology’s complete valuation and funding history, request access »

Beiqi Biology Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
37 Interactive Entertainment Corporation Minority
Shanghai Yanyuan Private Equity Fund Management Growth/Expansion Minority
Capital Science and Technology Development Group Venture Capital Minority
Green Pine Capital Partners Venture Capital Minority
Xinyi Asset Management Asset Manager Minority
You’re viewing 5 of 12 investors. Get the full list »

Beiqi Biology FAQs

  • When was Beiqi Biology founded?

    Beiqi Biology was founded in 2022.

  • Where is Beiqi Biology headquartered?

    Beiqi Biology is headquartered in Beijing, China.

  • What industry is Beiqi Biology in?

    Beiqi Biology’s primary industry is Drug Discovery.

  • Is Beiqi Biology a private or public company?

    Beiqi Biology is a Private company.

  • What is Beiqi Biology’s current revenue?

    The current revenue for Beiqi Biology is .

  • How much funding has Beiqi Biology raised over time?

    Beiqi Biology has raised $13.8M.

  • Who are Beiqi Biology’s investors?

    37 Interactive Entertainment, Shanghai Yanyuan Private Equity Fund Management, Capital Science and Technology Development Group, Green Pine Capital Partners, and Xinyi Asset Management are 5 of 12 investors who have invested in Beiqi Biology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process